AstraZeneca launches integrated genomics approach to transform drug discovery and development
AstraZeneca and its global biologics research and development arm, MedImmune, today announced an integrated genomics initiative to transform drug discovery and development across its entire research and development pipeline.
Click on this link for more information.
